1. Molecular hallmarks of cancer
    Michael J. Birrer et al, 2023, DiSaia and Creasman Clinical Gynecologic Oncology CrossRef
  2. Successful anti-PD-1 therapy in metastatic endometrial cancer with microsatellite instability: a case report
    T. T. Andabekov et al, 2019, Tumors of female reproductive system CrossRef
  3. The utility of immunohistochemical testing for mismatch repair proteins in fine needle aspiration specimens of pancreatic adenocarcinoma
    Daniel Mettman et al, 2020, Annals of Diagnostic Pathology CrossRef
  4. MicroRNA as Epigenetic Modifiers in Endometrial Cancer: A Systematic Review
    Amélia Favier et al, 2021, Cancers CrossRef
  5. Targeted sequencing of genes associated with the mismatch repair pathway in patients with endometrial cancer
    Ashish Kumar Singh et al, 2020, PLOS ONE CrossRef
  6. Somatic Nonepigenetic Mismatch Repair Gene Aberrations Underly Most Mismatch Repair–Deficient Lynch-Like Tumors
    Lisa Elze et al, 2021, Gastroenterology CrossRef
  7. A clinical case of complete regression of a metastatic focus of endometrial cancer during check-point inhibitor therapy
    A.E. Protasova et al, 2020, Onkologiya. Zhurnal imeni P.A.Gertsena CrossRef
  8. DNA mismatch repair in cancer
    Marina Baretti et al, 2018, Pharmacology & Therapeutics CrossRef
  9. Pitfalls in mononucleotide microsatellite repeats instability assessing (MSI) in the patients with B-cell lymphomas
    Kseniia Andreevna Sychevskaya et al, 2021, Russian Clinical Laboratory Diagnostics CrossRef
  10. A potpourri of pathogenetic pathways in endometrial carcinoma with a focus on Lynch Syndrome
    Reubina Wadee et al, 2019, Annals of Diagnostic Pathology CrossRef
  11. Molecular Pathology of Endometrial Carcinoma: A General Appraisal
    Alessia Di Lorito et al, 2022, The Yokohama System for Reporting Endometrial Cytology CrossRef
  12. Clinical and morphological portrait of tumors with microsatellite instability
    A. A. Musaelyan et al, 2021, Advances in Molecular Oncology CrossRef
  13. Endometrial Tumors with MSI-H and dMMR Share a Similar Tumor Immune Microenvironment
    Yunfeng Song et al, 2021, OncoTargets and Therapy CrossRef
  14. Clinical Outcomes of Patients with Recurrent Microsatellite-Stable Endometrial Cancer in Early-Phase Immunotherapy Clinical Trials
    Jeffrey A. How et al, 2022, Cancers CrossRef
  15. Quantification of Women Who Could Benefit from Hormone Therapy after Endometrial Cancer Treatment: An Analysis of SEER Data
    Ambrogio P. Londero et al, 2022, Current Oncology CrossRef
  16. Can Cisplatin Therapy Be Improved? Pathways That Can Be Targeted
    Reem Ali et al, 2022, International Journal of Molecular Sciences CrossRef
  17. Pembrolizumab-induced severe rejection and graft intolerance syndrome resulting in renal allograft nephrectomy
    Sandeep A Padala et al, 2021, Journal of Oncology Pharmacy Practice CrossRef
  18. WRN helicase is a synthetic lethal target in microsatellite unstable cancers
    Edmond M. Chan et al, 2019, Nature CrossRef
  19. The significance of microsatellite instability in endometrial cancer
    Maria-Bianca Anca-Stanciu et al, 2021, Obstetrica şi Ginecologia CrossRef
  20. EXPERIENCE OF APPLICATION OF ANTI PD-1 THERAPY IN MMR-DEFICIENCY ENDOMETRIAL CANCER
    K. G. Cham et al, 2018, Malignant tumours CrossRef
  21. Molecular Diagnosis of Uterine Cancer
    Rajani Rai et al, 2019, Molecular Diagnostics in Cancer Patients CrossRef
  22. Organoid technology in female reproductive biomedicine
    Heidar Heidari-Khoei et al, 2020, Reproductive Biology and Endocrinology CrossRef
  23. Expression of Programmed Cell Death-L1 (PD-L1) Protein and Mismatch Repair Mutations in Orbital Tumours-a Pilot Study
    Mohammad A AlSemari et al, 2022, European Journal of Ophthalmology CrossRef
  24. Epigenetic alterations in female urogenital organs cancer: Premise, properties, and perspectives
    Abdelkareem A. Ahmed et al, 2020, Scientific African CrossRef
  25. A phase 2 evaluation of pembrolizumab for recurrent Lynch‐like versus sporadic endometrial cancers with microsatellite instability
    Stefania Bellone et al, 2022, Cancer CrossRef
  26. Identification of possible Lynch syndrome in endometrial carcinomas at a public hospital in South Africa
    R Wadee et al, 2020, Southern African Journal of Gynaecological Oncology CrossRef
  27. Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Metastases from Endometrial Cancer
    Tommaso Cornali et al, 2018, Annals of Surgical Oncology CrossRef
  28. Managing Difficulties of Microsatellite Instability Testing in Endometrial Cancer-Limitations and Advantages of Four Different PCR-Based Approaches
    Janna Siemanowski et al, 2021, Cancers CrossRef